Germany Veterinary Reference Laboratory Market Overview, 2031

Key Insights

• Germany's veterinary reference laboratory market operates within a mature European animal health landscape characterized by a stable companion animal population and a substantial, though structurally transforming, livestock sector. According to the Friedrich-Loeffler-Institut (FLI), Germany has approximately 19.5 million cats and 10.5 million dogs, making them among the most popular pets and reflecting the deep integration of companion animals into German households. A global ranking of domestic dog populations places Germany seventh with approximately 10.3 million dogs, demonstrating the significant scale of the companion animal market. The livestock sector, while experiencing long-term structural decline, remains considerable, with the cattle herd at approximately 10.4 million animals (including 3.6 million dairy cows) and the pig population at approximately 21.0 million as of May 2026.
• The German veterinary reference laboratory market is characterized by a highly sophisticated and rigorously quality-assured infrastructure. The Friedrich-Loeffler-Institut (FLI) serves as the National Reference Laboratory (NRL) for more than 70 notifiable and reportable animal diseases, with all reference laboratories accredited by the Deutsche Akkreditierungsstelle GmbH (DAkkS) according to ISO/IEC 17025. These laboratories clarify suspected cases, provide advice to veterinary authorities, and conduct ring trials and quality assurance measures for animal disease diagnostics across Germany.
• Regulatory oversight for veterinary diagnostics in Germany is administered through a comprehensive framework under the German Animal Health Act (Tiergesundheitsgesetz - TierGesG), which designates the FLI as the National Reference Laboratory and establishes the legal basis for diagnostic activities. The Deutsche Akkreditierungsstelle GmbH (DAkkS) provides ISO/IEC 17025 accreditation for testing laboratories, ensuring international quality standards for veterinary diagnostic services. The EU Implementing Regulation 2018/1882 establishes disease classification categories, with laboratories requiring additional designation as official laboratories for diagnosis of category A or B diseases.
• The Ordinance on Animal Pathogens regulates activities involving animal pathogens, requiring permits for diagnostic examinations, with exemptions for veterinarians and veterinary clinics conducting tests within their practice. The German market is seeing increasing participation from commercial reference laboratories serving both companion animal and livestock sectors, with global leaders including IDEXX Laboratories, Zoetis, and Neogen Corporation maintaining significant presence, alongside regional specialized providers such as INDICAL BIOSCIENCE GmbH, EUROIMMUN, and Fassisi GmbH.

Market Outlook
• According to the research report, " Germany Veterinary Reference Laboratory Market Overview, 2031," published by Bonafide Research, the Germany Veterinary Reference Laboratory Market is anticipated to grow at more than 8.06% CAGR from 2026 to 2031.
• A defining characteristic of the German veterinary reference laboratory market is the rigorous quality assurance framework and the integration of molecular diagnostics into national disease surveillance programs. The FLI's network of more than 70 national reference laboratories, all DAkkS-accredited according to ISO/IEC 17025, ensures the highest standards of diagnostic accuracy. The adoption of molecular diagnostics, including PCR, next-generation sequencing, and digital PCR technologies, has accelerated significantly, driven by the need for rapid pathogen identification and antimicrobial resistance surveillance.
• Germany's national veterinary reference laboratory network, comprising the FLI as the apex reference laboratory, regional state laboratories, and private diagnostic facilities, provides the backbone of veterinary diagnostic infrastructure. The FLI, headquartered on the island of Riems, operates multiple sites across Germany and coordinates diagnostic activities for notifiable diseases. On the international level, the FLI has been designated as a Collaborating Centre for Zoonoses in Europe by the WOAH and houses WOAH reference laboratories for classical swine fever, avian influenza, rabies, and other diseases. The Food and Agriculture Organization (FAO) has designated the FLI as a Reference Centre for Influenza in Animals, Newcastle Disease of Poultry, Classical Swine Fever, and Rabies, and the WHO has designated a Collaborating Centre for Rabies Surveillance and Research at the FLI.
• The market also reflects Germany's strategic emphasis on One Health, zoonotic disease surveillance, and food safety. The Animal Health Act (TierGesG) provides the regulatory foundation for disease control measures and laboratory diagnostics, designating the FLI as the National Reference Laboratory. The requirement for permits or notifications for activities involving animal pathogens under the Ordinance on Animal Pathogens ensures that diagnostic activities are conducted under appropriate biosafety and biosecurity conditions. The FLI serves as the approval body for in vitro diagnostics for the detection of notifiable animal diseases and supports the competent authorities in implementing EU regulations. The livestock sector's contribution to the German economy, despite ongoing structural transformation, continues to drive demand for disease surveillance and food safety testing. The German companion animal diagnostics market accounted for 18.9% revenue share of the European market in 2025, reflecting Germany's significant position in the regional diagnostic landscape.



Market Dynamics

Driver: Stable companion animal population and evolving pet ownership trends
The German veterinary reference laboratory market is significantly driven by the stable companion animal population and the ongoing humanization of pets. Germany has approximately 19.5 million cats and 10.5 million dogs, with pets being particularly popular among families with children and increasingly regarded as full members of the family. The dog population of approximately 10.3 million ranks Germany seventh globally. The growing prevalence of chronic conditions in aging pets drives demand for routine and specialized diagnostic testing. Pet owners increasingly view their animals as family members, with willingness to invest in advanced diagnostic services, including molecular testing and specialized oncology screening. The companion animal diagnostics market in Germany accounted for 18.9% revenue share of the European market in 2025, reflecting the significant scale of companion animal diagnostic activities.

Driver: Structural transformation and disease surveillance in the livestock sector
Germany's livestock sector, despite experiencing long-term structural decline, continues to drive significant demand for diagnostic testing. The cattle herd stands at approximately 10.4 million animals (including 3.6 million dairy cows), while the pig population is approximately 21.0 million. The number of farms with livestock has declined substantially by 40% for pigs and 18.7% for cattle over the past decade with average farm sizes increasing, driving consolidation of veterinary services and diagnostic purchasing decisions. The national animal disease surveillance system, coordinated through the FLI's network of more than 70 national reference laboratories, conducts surveillance programs for notifiable diseases including classical swine fever, avian influenza, foot-and-mouth disease, and transmissible spongiform encephalopathies. The dairy sector, with 3.6 million dairy cows, generates demand for reproductive and herd health testing.



Challenge: Veterinary workforce shortages and regional disparities in access
A principal challenge facing the German veterinary reference laboratory market is the limited availability of skilled veterinary professionals and the uneven distribution of diagnostic infrastructure. While the FLI and major state laboratories maintain world-class diagnostic capabilities, the limited availability of specialized veterinary pathologists and laboratory scientists is a significant constraint. Geographic disparities persist, with diagnostic infrastructure concentrated in major agricultural regions such as Bavaria and Lower Saxony, while some areas have limited access to reference laboratory services. The complex regulatory framework governing activities with animal pathogens requires permits or notifications, proof of expertise (veterinary degree plus three years' experience), and proof of suitable premises. High costs associated with advanced diagnostic equipment and testing create barriers for smaller veterinary practices and laboratories. Germany's companion animal diagnostics market accounted for 18.9% of the European market in 2025 , yet access to specialized diagnostics remains uneven across regions.

Trend: Expansion of molecular diagnostics and integrated surveillance networks
The German veterinary reference laboratory market is experiencing a significant transformation toward molecular diagnostics and integrated surveillance systems. The FLI's network of national reference laboratories, all DAkkS-accredited according to ISO/IEC 17025, has embraced molecular diagnostics for pathogen identification and disease surveillance. Molecular diagnostics enable pathogen-specific identification, resistance profiling, and outbreak tracing through PCR, next-generation sequencing, and digital PCR technologies. The FLI conducts ring trials and publishes official sampling and investigation procedures for notifiable animal diseases, ensuring consistent diagnostic quality across the national laboratory network. The adoption of digital platforms and Laboratory Information Management Systems (LIMS) is improving turnaround times and enabling real-time data sharing for disease surveillance. The FLI's Annual Animal Health Report provides comprehensive data on disease surveillance and diagnostic activities, supporting evidence-based policymaking.

Policies

• Animal Health Act (Tiergesundheitsgesetz - TierGesG): The foundational legislation governing animal disease prevention and control in Germany. Section 27 of the Act designates the Friedrich-Loeffler-Institut as the National Reference Laboratory (NRL) for more than 70 notifiable and reportable animal diseases. The Act establishes the regulatory framework for disease surveillance, laboratory testing, and outbreak response.
• DAkkS ISO/IEC 17025 Accreditation: The Deutsche Akkreditierungsstelle GmbH (DAkkS) provides ISO/IEC 17025 accreditation for testing laboratories, establishing international quality and technical competence standards. All FLI national reference laboratories are DAkkS-accredited according to ISO/IEC 17025, ensuring the highest standards of diagnostic accuracy and reliability.
• EU Implementing Regulation 2018/1882:Establishes the classification of animal diseases into categories A and B. For diagnosis of category A or B diseases, laboratories require an additional designation as an official laboratory. This designation is typically granted by state authorities such as the Bavarian State Office for Health and Food Safety or equivalent state institutions.
• FLI Role as Approval Body:The FLI serves as the approval body for in vitro diagnostics for the detection of notifiable animal diseases. It supports the competent authorities in implementing the regulations of the EU Animal Welfare Slaughter Regulation. The offices of the Standing Commission on Vaccination in Veterinary Medicine (StIKo Vet) and of the National Expert Commission "Mosquitoes as vectors of pathogens" are located at the FLI.

Segment Analysis

Germany Veterinary Reference Laboratory Market Overview, 2031 By Service Type
• Clinical Chemistry represents the largest revenue-generating service category in the German veterinary reference laboratory market, driven by routine blood chemistry panels and metabolic profiling tests performed across companion animal and livestock healthcare settings. The stable pet population of approximately 19.5 million cats and 10.5 million dogs provides a substantial addressable market for clinical chemistry services. Clinical chemistry services are utilized for routine wellness testing, disease diagnosis, treatment monitoring, and pre-surgical assessment. The growing emphasis on preventive care and early disease detection continues to drive demand for comprehensive chemistry panels. Veterinary hospitals and clinics typically perform complete blood count (CBC) and serum chemistry panels as part of routine wellness exams.
• Immunodiagnostics represents a significant and growing service category in Germany, enabling rapid and accurate detection of infectious and chronic diseases. Immunodiagnostic services include ELISA-based testing, serological assays, rapid test kits, and immunofluorescence, supporting infectious disease screening, vaccine titer monitoring, and endocrine disorder diagnosis. The national surveillance programs for livestock diseases, coordinated through the FLI's network of national reference laboratories, utilize immunodiagnostic assays for screening and confirmation. The FLI's ISO/IEC 17025 accreditation ensures immunodiagnostic testing meets international quality standards.
• Hematology maintains a significant position within the German market, driven by the fundamental role of complete blood count (CBC) analysis in routine and emergency veterinary medicine. Hematology services are utilized for diagnosis of anemia, infection, inflammation, immune disorders, and hematological abnormalities. The increasing prevalence of hematological disorders in aging companion animals continues to support steady demand for hematology testing. Automated hematology analyzers have become standard equipment in commercial reference laboratories, while state laboratories and the FLI maintain hematological testing capabilities for disease surveillance applications. The DAkkS accreditation framework ensures hematology testing meets ISO/IEC 17025 standards.
• Molecular Diagnostics represents the fastest-growing service category in the German market and is projected to grow at the highest CAGR. Molecular diagnostics enable pathogen-specific identification, resistance profiling, and outbreak tracing through PCR, next-generation sequencing, and digital PCR technologies. The FLI's network of national reference laboratories utilizes molecular diagnostics for detection of notifiable diseases including classical swine fever, avian influenza, and foot-and-mouth disease. The FLI publishes official sampling and investigation procedures for notifiable animal diseases, ensuring standardized molecular diagnostic protocols across the national laboratory network. Beyond infectious disease testing, molecular diagnostics are increasingly utilized for genetic screening, breed improvement, and research applications. The FLI's role as a WOAH Collaborating Centre for Zoonoses in Europe supports the adoption of advanced molecular diagnostic technologies for zoonotic disease surveillance.
• Others encompasses microbiology, parasitology, toxicology, and anatomic pathology services. These specialized services are critical for comprehensive diagnostic workups and are typically outsourced to reference laboratories due to the specialized equipment and expertise required. Parasitology testing remains essential for routine wellness screening, particularly in livestock production. Anatomic pathology supports cancer diagnosis and surgical planning, with growing demand driven by increased cancer incidence in aging pets.

Germany Veterinary Reference Laboratory Market Overview, 2031 By Animal Type
• Companion Animals represent the largest revenue-generating animal type segment in the German veterinary reference laboratory market, with approximately 69.11% market share in 2025. This dominance is driven by Germany's stable pet population of approximately 19.5 million cats and 10.5 million dogs , with the dog population of approximately 10.3 million ranking seventh globally. The growing prevalence of chronic conditions in aging pets drives demand for routine and specialized diagnostic testing. Pet owners increasingly view their animals as family members, with willingness to invest in advanced diagnostic services. The German companion animal diagnostics market accounted for 18.9% revenue share of the European market in 2025. The expansion of companion animal diagnostics across clinical chemistry, immunodiagnostics, hematology, and molecular diagnostics reflects the comprehensive testing needs of the companion animal population. The diagnostic laboratories segment held the largest market share in the Europe companion animal diagnostics market in 2025, reflecting the reliance on reference laboratories for companion animal testing. The trend toward pet humanization and premiumization supports the adoption of advanced diagnostic services for companion animals.
• Production Animals represent a substantial and growing segment of the German market and are forecast to experience the fastest growth during the forecast period. Germany's livestock population includes approximately 10.4 million cattle (including 3.6 million dairy cows) and approximately 21.0 million pigs as of May 2026. The number of farms with livestock has declined substantially by 40% for pigs and 18.7% for cattle over the past decade with average farm sizes increasing, driving consolidation of veterinary services and diagnostic purchasing decisions. The national animal disease surveillance system, coordinated through the FLI's network of more than 70 national reference laboratories, conducts surveillance programs for notifiable diseases including classical swine fever, avian influenza, foot-and-mouth disease, and transmissible spongiform encephalopathies. Livestock producers increasingly send samples to reference laboratories to control outbreaks that threaten herd health and productivity. The dairy sector, with 3.6 million dairy cows, generates demand for reproductive and herd health testing.

Germany Veterinary Reference Laboratory Market Overview, 2031 By End User
• Veterinary Hospitals and Clinics represent the largest end-user segment in the German veterinary reference laboratory market. With veterinary clinics and hospitals distributed across the country, general practices increasingly outsource complex tests to reference laboratories to avoid the overhead of specialized equipment and staff. Major metropolitan areas including Berlin, Munich, Hamburg, and Cologne have high concentrations of veterinary practices that utilize reference laboratory services. The German veterinary professional framework, administered through the state veterinary chambers, ensures quality standards across veterinary practices. The growth of specialty veterinary hospitals and referral centers has increased demand for comprehensive diagnostic testing. The stable pet population of approximately 19.5 million cats and 10.5 million dogs has driven expansion of the veterinary services market. The regulatory framework, which exempts veterinarians from the permitting requirement for diagnostic examinations within their practice, supports the expansion of veterinary clinic-based diagnostic activities.
• Research Institutes represent a significant end-user segment in Germany. Academic veterinary institutions, pharmaceutical research organizations, and animal-health research institutions rely on reference laboratories for advanced molecular testing, genetic analysis, and disease surveillance studies. The FLI, as the national reference laboratory, collaborates with research institutions on diagnostic development and disease surveillance. Research institutes demand research-grade analytics and specialized testing services, driving demand for high-complexity reference laboratory testing. The FLI's role as a WOAH Collaborating Centre for Zoonoses in Europe supports research activities for zoonotic disease surveillance.
• In-House Laboratories represent a complementary channel in Germany. Veterinary practices and animal-health facilities maintain internal laboratory capabilities for routine testing, utilizing reference laboratories for specialized, confirmatory, high-complexity, or testing services that cannot be efficiently performed internally. The regulatory framework exempts veterinarians from the permitting requirement for diagnostic examinations within their practice, supporting in-house testing activities. The German market for veterinary point-of-care diagnostics includes analyzers and consumables for in-house testing. The DAkkS accreditation framework ensures quality standards for laboratories performing official testing. The in-house channel is primarily used to calculate the outsourcing rate, not double-counted as market revenue. Veterinary diagnostic equipment manufacturers have expanded in-house testing capabilities through portable analyzers and rapid test kits, though reference laboratories remain essential for complex and high-volume testing.

Germany Veterinary Reference Laboratory Procedure Economics
• Veterinary reference laboratory testing in Germany represents a critical component of comprehensive veterinary care, requiring specialized equipment, trained personnel, quality control, and timely reporting. The market is characterized by public sector laboratories under the FLI and state authorities, and private commercial laboratories.
• FLI National Reference Laboratory Network: The Friedrich-Loeffler-Institut acts as National Reference Laboratory for more than 70 notifiable animal diseases. All reference laboratories are DAkkS-accredited according to ISO/IEC 17025. The FLI clarifies suspected cases, advises veterinary authorities, conducts ring trials, and performs quality assurance measures. The FLI publishes official sampling and investigation procedures for notifiable animal diseases and the Annual Animal Health Report. On the international level, the FLI serves as a WOAH Collaborating Centre for Zoonoses in Europe and houses WOAH reference laboratories for multiple diseases. The FLI is also a WHO Collaborating Centre for Rabies Surveillance and Research and FAO Reference Centre for multiple diseases.
• State Official Laboratories: Regional state laboratories, such as the Bavarian State Office for Health and Food Safety, perform official diagnostic services for disease surveillance and food safety. Laboratories performing diagnosis of category A or B diseases require designation as an official laboratory. These laboratories maintain DAkkS accreditation and participate in the FLI's ring trials for quality assurance.
• Commercial Reference Laboratories: Private veterinary reference laboratories serve the companion animal and livestock markets. Commercial laboratories must comply with the Ordinance on Animal Pathogens, requiring permits or notifications for activities involving animal pathogens. Commercial laboratories provide testing services to veterinary hospitals and clinics, with service offerings including clinical chemistry, hematology, immunodiagnostics, and molecular diagnostics. Key commercial players include IDEXX Laboratories, Zoetis, Neogen Corporation, INDICAL BIOSCIENCE GmbH, EUROIMMUN Medizinische Labordiagnostika AG, and Fassisi GmbH.
• In veterinary hospitals and clinics, the cost of a comprehensive diagnostic workup varies depending on the complexity of the test panel, geographic location, and laboratory pricing. Routine diagnostic tests vary based on test type and provider. Molecular diagnostic tests, including PCR panels, represent a growing revenue source for reference laboratories. The companion animal diagnostics market in Germany accounted for 18.9% of the European market revenue in 2025, reflecting the significant scale of diagnostic expenditure.


Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Veterinary Reference Laboratory Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Service Type
• Clinical Chemistry
• Hematology
• Immunodiagnostics
• Molecular Diagnostics
• Others

By Animal Type
• Companion Animals
• Livestock Animals

By End User
• Veterinary Hospitals and Clinics
• Research Institutes
• In-House Laboratories